Cargando…
Imaging immunomodulatory treatment responses in a multiple sclerosis mouse model using hyperpolarized (13)C metabolic MRI
BACKGROUND: In recent years, the ability of conventional magnetic resonance imaging (MRI), including T(1) contrast-enhanced (CE) MRI, to monitor high-efficacy therapies and predict long-term disability in multiple sclerosis (MS) has been challenged. Therefore, non-invasive methods to improve MS lesi...
Autores principales: | Guglielmetti, Caroline, Cordano, Christian, Najac, Chloé, Green, Ari J., Chaumeil, Myriam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202949/ https://www.ncbi.nlm.nih.gov/pubmed/37217574 http://dx.doi.org/10.1038/s43856-023-00300-1 |
Ejemplares similares
-
Detection of inflammatory cell function using (13)C magnetic resonance spectroscopy of hyperpolarized [6-(13)C]-arginine
por: Najac, Chloé, et al.
Publicado: (2016) -
Hyperpolarized (13)C metabolic imaging detects long-lasting metabolic alterations following mild repetitive traumatic brain injury
por: Chaumeil, Myriam, et al.
Publicado: (2023) -
In vivo metabolic imaging of Traumatic Brain Injury
por: Guglielmetti, Caroline, et al.
Publicado: (2017) -
Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring
por: Chaumeil, Myriam M., et al.
Publicado: (2016) -
In vivo investigation of hyperpolarized [1,3-(13)C(2)]acetoacetate as a metabolic probe in normal brain and in glioma
por: Najac, Chloé, et al.
Publicado: (2019)